Interleukin-10-Treated Dendritic Cells Modulate Immune Responses of Naive and Sensitized T Cells In Vivo

This publication has 23 references indexed in Scilit:

• Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo
  Immunity, 1994
• Interleukin‐10 inhibits B7 and intercellular adhesion molecule‐1 expression on human monocytes
  European Journal of Immunology, 1994
• Interleukin‐10 production by human carcinoma cell lines and its relationship to interleukin‐6 expression
  International Journal of Cancer, 1993
• Cytokine gene expression in primary brain tumours, metastases and meningiomas suggests specific transcription patterns
  European Journal Of Cancer, 1993
• The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro.
  Journal of Clinical Investigation, 1992
• Differential effects of IL-4 and IL-10 on IL-2-induced IFN-γ synthesis and lymphokine-activated killer activity
  International Immunology, 1992
• Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
  The Journal of Experimental Medicine, 1991
• Signals arising from antigen-presenting cells
  Current Opinion in Immunology, 1991
• Induction by Antigen of Intrathymic Apoptosis of CD4 ⁺ CD8 ⁺ TCR ^lo Thymocytes in Vivo
  Science, 1990
• Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro.
  The Journal of Experimental Medicine, 1985